Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT03535142 Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT03535142
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are over 18 years old.
  • You have a Body Mass Index (BMI) over 35 (which is considered severely obese) and are scheduled for weight loss surgery at the Hospital of South West Jutland in Denmark, OR you have a BMI over 35 but do not wish to have weight loss surgery.
  • You are able and willing to sign a written consent form agreeing to take part.

Who may not be able to join:

  • You currently have an active viral hepatitis infection (a type of liver infection caused by a virus).
  • You are unwilling or unable to give your consent to participate.
  • You have a medical reason why a liver biopsy (a small sample taken from the liver) would not be safe for you (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mette M Lauridsen, MD, PhD, Esbjerg Hospital - University Hospital of Southern Denmark

Phone: 4579182000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Registry
ClinicalTrials.gov
Start date
15 August 2018
Est. completion
1 June 2035

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Number of participants who will die during the follow up period in case and control group

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov